Drug Database
Back to search

Belgium· BE-AMP-SAM429405-00

Flutiform 50 µg - 5 µg

A formoterol und fluticason product containing fluticasone propionate, registered in Belgium by Mundipharma. The same ATC class is registered in 9 of our 19 countries.

ATC R03AK11

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedFlutiform 50 µg - 5 µgATCR03AK11REGISTER NO.BE-AMP-SAM429405-00PACKS LISTED2CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fluticasone propionateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Formoterol und fluticason is registered in 9 of 19 countries.

Countries holding a registration under ATC R03AK11 (formoterol und fluticason), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search formoterol und fluticason products by name

Formoterol und fluticason · ATC R03AK11

9 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Fluticasone Propionate
Manufacturer
Mundipharma
Country
Belgium (BE)
ATC code
R03AK11
ATC class
Formoterol und Fluticason
Defined daily dose
24 mcg, Inhal
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

1 priced
  • be_apb
    3023363
    EUR 34.87
  • be_apb
    7703119

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under R03AK11

Formoterol und fluticason, as other registers publish it.

All formoterol und fluticason products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/4fc09f81-b544-4571-a320-631c6b21be17
GET /v1/drugs/4fc09f81-b544-4571-a320-631c6b21be17?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Pressurised inhalation, suspension",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Flutiform 50 µg - 5 µg",
  "name_fr": "Flutiform 50 µg - 5 µg",
  "name_nl": "Flutiform 50 µg - 5 µg",
  "amp_code": "SAM429405-00",
  "strengths": [
    "0.0500",
    "0.0050",
    "1.0000",
    "0.0240"
  ],
  "pack_count": 1,
  "substances": [
    "Fluticasone Propionate",
    "Formoterol Fumarate Dihydrate",
    "Anhydrous Ethanol",
    "Sodium Cromoglicate"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Formoterol and Fluticasone",
  "authorisation_numbers": [
    "BE429405"
  ]
}
API referenceMCP serverPlans

See everything about formoterol und fluticason.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console